1. Home
  2. Labeler Index
  3. Merck Sharp & Dohme Llc
  4. 0006-4827
  5. NDC Package Code: 0006-4827-00 Varivax

NDC Package 0006-4827-00 Varivax

Varicella Virus Vaccine Live Injection, Powder, Lyophilized, For Suspension Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0006-4827-00
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4827-01)
Product Code:
0006-4827
Proprietary Name:
Varivax
Non-Proprietary Name:
Varicella Virus Vaccine Live
Substance Name:
Varicella-zoster Virus Strain Oka/merck Live Antigen
Usage Information:
VARIVAX® is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.
11-Digit NDC Billing Format:
00006482700
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1292457 - varicella virus vaccine live (VAR) 1350 PFU in 0.5 ML Injection
  • RxCUI: 1292457 - 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection
  • RxCUI: 1292457 - varicella-zoster virus vaccine live (Oka-Merck) strain 1350 PFU per 0.5 ML Injection
  • RxCUI: 1292459 - VARIVAX vaccine 0.5 ML Injection
  • RxCUI: 1292459 - 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax]
    • Product Type:
    Vaccine
    Labeler Name:
    Merck Sharp & Dohme Llc
    Dosage Form:
    Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN 1350 [PFU]/.5mL
    • Pharmacologic Class(es):
  • Actively Acquired Immunity - [PE] (Physiologic Effect)
  • Chickenpox Vaccine - [CS]
  • Herpes Zoster Vaccine - [CS]
  • Live Attenuated Herpes Zoster Virus Vaccine - [EPC] (Established Pharmacologic Class)
  • Live Attenuated Varicella Zoster Virus Vaccine - [EPC] (Established Pharmacologic Class)
  • Vaccines, Attenuated - [CS]
    • Sample Package:
    No
    FDA Application Number:
    BLA103552
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    03-17-1995
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0006-4827-00?

    The NDC Packaged Code 0006-4827-00 is assigned to a package of 10 vial, single-dose in 1 carton / .5 ml in 1 vial, single-dose (0006-4827-01) of Varivax, a vaccine label labeled by Merck Sharp & Dohme Llc. The product's dosage form is injection, powder, lyophilized, for suspension and is administered via subcutaneous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0006-4827 included in the NDC Directory?

    Yes, Varivax with product code 0006-4827 is active and included in the NDC Directory. The product was first marketed by Merck Sharp & Dohme Llc on March 17, 1995 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0006-4827-00?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0006-4827-00?

    The 11-digit format is 00006482700. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20006-4827-005-4-200006-4827-00